Delivery Order SPE2DR25D2006-SPE2DR26F56TB
- Not listed
- The Defense Logistics Agency awarded a $5,061.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a non-set-aside competitive award with an ultimate completion date of December 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement action within the federal...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a $2,477.82 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. This firm fixed price contract, with an ultimate completion date of June 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.5% (150 mg/30 ml) on November 7, 2025, with a ceiling value of $3,164.35 and ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.46 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,810.25 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials. This firm fixed price, non-set-aside contract is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL units) with a ceiling value of $5,149.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Ropivacaine 0.2% (200 mg/100 mL) in 100 mL units, with a ceiling value of $1,419.66 and a firm fixed price structure. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was issued with no set-aside...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56TBDelivery Order
The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and distribution center. This award reflects AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. The company's expansive IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The delivery order for Ropivacaine, a local anesthetic medication, exemplifies the routine pharmaceutical procurement activities conducted under this prime vendor vehicle, demonstrating AmerisourceBergen's continued capability to fulfill federal medical procurement requirements through competitive acquisition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/11/25 |